Tony Wood, GSK CSO

On Pfiz­er's heels, GSK boasts 'tru­ly ex­cep­tion­al' PhI­II da­ta for RSV vac­cine — mak­ing a bee­line to FDA

Pfiz­er won’t be the on­ly drug­mak­er to file an RSV vac­cine with the FDA this year.

GSK — an­oth­er fron­trun­ner in the long race to de­vel­op …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.